Generate:Biomedicines has launched two global Phase III trials for GB-0895, an AI-engineered antibody for severe asthma dosed just twice a year, testing whether machine-designed biologics can clear the same bar as conventionally discovered drugs.
Genomics England's Generation Study is sequencing newborns' full genomes and using AI to sort millions of genetic variants into actionable results, catching rare treatable conditions in about 1 in 200 babies as the NHS plans a decade-long national rollout.
CMS has launched WISeR, a six-state pilot using AI to screen traditional Medicare claims for medical necessity through 2031, and while officials say it targets wasteful spending, physicians and patient advocates worry it will replicate the high overturn rates and delayed care already seen with AI-driven Medicare Advantage denials.
Catholic Health in Buffalo is using RapidAI to alert stroke teams within minutes instead of the 45 minutes diagnosis used to take, though physicians insist the AI only prioritizes cases and never replaces standard diagnostic steps.
A JAMA study of 1,800 clinicians found AI scribes saved 16 minutes of documentation time per eight-hour day, far less than vendors have promised, with benefits varying sharply by specialty and consistency of use.
Lausanne University Hospital's AI system HERACLES re-screens every patient for sepsis every six hours. A study of nearly 100,000 patient stays found in-hospital mortality for flagged cases fell from 20.54% to 15.27%.
Ergomotion's new Sleep Assist app tracks sleep through non-contact sensors built into the bed base itself, letting users ask its AI assistant plain-language questions about their sleep instead of parsing another wearable's data dashboard.
An NIH analysis of 11 million days of Fitbit data from nearly 30,000 All of Us participants found that a year of step data predicts far more health outcomes than a single day's readout, including unexpected links to chronic pain and autoimmune disease.
Oura introduced a proprietary AI model built specifically for women's health questions inside its Oura Advisor assistant, reporting that users sent more than a million messages to the tool during testing — with 83% rating its answers reliable.
Nonprofit Every Cure uses AI to score thousands of existing drugs against tens of thousands of diseases, cutting a 100-day repurposing search to 17 hours, backed by $48.3 million in ARPA-H federal funding.